Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Accounts Payables (2022 - 2026)

HeartSciences (HSCS) has disclosed Accounts Payables for 4 consecutive years, with $317390.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accounts Payables rose 14.64% year-over-year to $317390.0, compared with a TTM value of $317390.0 through Oct 2025, up 14.64%, and an annual FY2025 reading of $318661.0, down 28.9% over the prior year.
  • Accounts Payables was $317390.0 for Q4 2025 at HeartSciences, up from $283225.0 in the prior quarter.
  • Across five years, Accounts Payables topped out at $1.1 million in Q4 2023 and bottomed at $276848.0 in Q4 2024.
  • Average Accounts Payables over 4 years is $534794.2, with a median of $448183.0 recorded in 2024.
  • The sharpest move saw Accounts Payables soared 36.85% in 2023, then crashed 74.56% in 2024.
  • Year by year, Accounts Payables stood at $795266.0 in 2022, then skyrocketed by 36.85% to $1.1 million in 2023, then plummeted by 74.56% to $276848.0 in 2024, then increased by 14.64% to $317390.0 in 2025.
  • Business Quant data shows Accounts Payables for HSCS at $317390.0 in Q4 2025, $283225.0 in Q3 2025, and $318661.0 in Q2 2025.